Showing 1 - 1 results of 1 for search 'Xiaoya Lou', query time: 0.02s Refine Results
  1. 1
    Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?

    Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States? by Huiting Lin, Wenhua Wu, Xiaoya Lou, Yiming Wang, Hong Sun, Jiaqin Cai, Suyan Liu, Xiaoxia Wei

    Published 2024-04-01
    Get full text
    Article

Search Tools: